Measuring glycaemic variation.
The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various metrics of GV in qualitatively different datasets. The purpose of this review is to discuss the properties of 8 of the more commonly used metrics (M-value, MAGE, "J"-index, CONGA, BG rate of change, ADRR, Lability/HYPO score and GRADE). Comparable metrics that can be used to measure continuous glycaemic measurements (CGM) (SDBGL, "J"-index, MAGE, CONGA, GRADE) were then compared in assessing diabetic and non-diabetic datasets. In non-diabetic conditions there was very close correlation (correlation coefficients >0.92) between SDBGL, MAGE and CONGA, however under diabetic conditions the correlation coefficients of the GV metrics diminished significantly. The varying GV metrics have varying inherent properties depending upon the purpose for which they were designed and should not be seen as being interchangeable. Investigators therefore need to be clear about the nature of their enquiry of GV and choose an appropriate metric.
Cameron
Fergus J
FJ
Dept of Endocrinology & Diabetes, Royal Children's Hospital, University of Melbourne, Murdoch Children's Research Institute Parkville, Victoria, Australia. fergus.cameron@rch.org.au
Donath
Susan M
SM
Baghurst
Peter A
PA
D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D006801:Humans; D007700:Kinetics; D018670:Monitoring, Ambulatory / Q000379:methods; D012016:Reference Values; D015203:Reproducibility of Results; D016896:Treatment Outcome
D001786:Blood Glucose